Clinical-epidemiological profile of patients with death from COVID-19 in a Brazilian hospital
Keywords:
COVID-19, Epidemiology, Hospitalization, Pandemics, Health ProfileAbstract
Objective: To identify the epidemiological profile of hospitalized patients who died from COVID-19 in a municipality in the Brazilian Northeast. Methods: Cross-sectional study, carried out using an instrument to collect epidemiological and clinical data from patients admitted to a public hospital due to COVID-19. The final sample comprised 134 patients. For data analysis, descriptive statistics were used. The Shapiro-Wilk test was used to verify data normality. Results: There was a predominance of females (57.2%), with a median of 71 years old. The most frequent clinical manifestations were O2 saturation < 95% (73.9%) and dyspnea (67.9%). Chronic cardiovascular disease (54.5%) was the main morbidity. Conclusion: The study made it possible to trace the epidemiological profile of hospitalized patients who died due to COVID-19 in 2020 and 2021 in a municipality in the northeast region of Brazil. It helps to assist health managers in the region when planning preventive measures and making decisions. Furthermore, it provides support for effective epidemiological monitoring, allowing for an agile response in the event of a new wave of COVID-19.
References
Sott MK, Bender MS, Silva Baum K. Covid-19 Outbreak in Brazil: Health, Social, Political, and Economic Implications. Int J Health Serv. 2022;52(4):442- 454. doi: https://doi.org/10.1177/00207314221122658
Tu H, Tu S, Gao S, Shao A, Sheng J. Current epidemiological and clinical features of COVID-19; a global perspective from China. J Infect. 2020;81(1):1-9. doi: https://doi.org/10.1016/j.jinf.2020.04.011
Ministério da Saúde (BR). Guia de vigilância epidemiológica Emergência de saúde pública de Importância nacional pela Doença pelo coronavírus 2019 – COVID-19. 2021. Available from: https://www.conasems.org.br/wp- content/uploads/2021/03/Guia-de-vigila%CC%82ncia- epidemiolo%CC%81gica-da-covid_19_15.03_2021.pdf
Hung YP, Lee JC, Chiu CW, Lee CC, Tsai PJ, Hsu IL, et al. Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?. Antibiotics (Basel). 2022;11(2):220. doi: https://doi.org/10.3390/antibiotics11020220
Ministério da Saúde. Coronavírus Brasil [Internet]. covid.saude.gov.br. 2023. Available from: https://covid.saude.gov.br/
Almeida Filho N, Barreto ML. Epidemiologia & Saúde: Fundamentos, métodos, aplicações. Brasil: Guanabara Koogan; 2014.
Vidal TI, Gaspar MDR, Bonatto S, Coelho FUA, Oliveira, RA, Fernandes, LC. Perfil clínico dos pacientes diagnosticados com Covid-19 internados em uma Unidade de Terapia Intensiva. REVISA. 2021; 10(4): 735-742. doi: https://doi.org/10.36239/revisa.v10.n4.p735a742
Alves RP, Carvalho JVB, Santos LASL, Souza VR, Costa AJ, Luna AA. Profile of adult patients with COVID-19 admitted to an intensive care unit. RSD. 2022;11(5):e43411528481. doi: https://doi.org/10.33448/rsd-v11i5.28481
Goulart LS, Santos KCF, Santos DAS, Mattos M. Características clínicas e laboratoriais da covid-19: uma análise na internação hospitalar. Rev Enferm Atual In Derme. 2021;95(36):e-021169. doi: https://doi.org/10.31011/reaid- 2021-v.95-n.36-art.1074
Instituto Brasileiro De Geografia E Estatística (IBGE). 2023. Available from: https://ftp.ibge.gov.br/Censos/Censo_Demografico_2022/Previa_da_Populac ao/POP2022_Municipios.pdf
Farias AG, Brito AAC, Silva JV, Cunha ATR, Queiroz JM, Freitas KOR, et al. Perfil epidemiológico dos pacientes hospitalizados com COVID-19 no município de Mossoró-RN. Rev Ciênc Plural. 2022;8(3):1-18. doi: https://doi.org/10.21680/2446-7286.2022v8n3ID28522
REVISA.2024 Abr-Jun; 13(2):489-501
Silva MF, Araújo MG, Araújo JNM, Cabral AEA, Dantas AC, Vitor AF
Desiderio VL, Fabio V, Cárnio EC, Godoy S, Silva HB, Marchi-Alves LM. Variáveis associadas ao desfecho clínico de pacientes hospitalizados por COVID-19. Rev Med. 2021;100(5):431-441. doi: https://doi.org/10.11606/issn.1679-9836.v100i5p431-44
Aquino EML, Silveira IH, Pescarini JM, Aquino R, Souza-Filho JA de, Rocha A dos S, et al. Medidas de distanciamento social no controle da pandemia de COVID-19: potenciais impactos e desafios no Brasil. Ciênc Saúde Coletiva. 2020;25(1):2423-2446. doi: https://doi.org/10.1590/1413- 81232020256.1.10502020
Buffon MR, Severo IM, Barcellos RA, Azzolin KO, Lucena AF. Critically ill COVID-19 patients: a sociodemographic and clinical profile and associations between variables and workload. Rev Bras Enferm. 2022;75(Suppl 1):e20210119. doi: https://doi.org/10.1590/0034-7167-2021-0119
Vieira YP, Soares AOJ, Nunes LS, Santos MA, Duro SMS, Saes MO. Profile and spatial distribution of COVID-19 deaths in the municipality of Rio Grande/RS in 2020. Medicina. 2022;55(3):e-187601. doi: https://doi.org/10.11606/issn.2176-7262.rmrp.2022.187601
Sousa CDK, Morais TC, Daboin BEG, Portugal I, Cavalcanti MPE, Echeimberg JO, et al. Epidemiological profile of COVID-19 in the State of Espírito Santo, Brazil, from
march 2020 to june 2021. J Hum Growth Dev. 2021;31(3):507-520. doi: https://doi.org/10.36311/jhgd.v31.12770
Bertsimas D, Lukin G, Mingardi L, Nohadani O, Orfanoudaki A, Stellato B, et al. COVID-19 mortality risk assessment: An international multi-center study. PLoS One. 2020;15(12):e0243262. doi: https://doi.org/10.1371/journal.pone.0243262
Orellana JDY, Cunha GM, Marrero L, Leite IC, Domingues CMAS, Horta BL. Mudanças no padrão de internações e óbitos por COVID-19 após substancial vacinação de idosos em Manaus, Amazonas, Brasil. Cad Saúde Pública. 2022;38(5):PT192321. doi: https://doi.org/10.1590/0102-311XPT192321
Moura EC, Escalante JC, Cavalcante FV, Barreto IVHC, Sanchez MN, Santos LMP. Covid-19: evolução temporal e imunização nas três ondas epidemiológicas, Brasil, 2020–2022. Rev Saude Publica. 2022;56(105). doi: https://doi.org/10.11606/s1518- 8787.2022056004907
Meireles GSP. COVID-19: a brief update for radiologists. Radiol Bras. 2020;53(5): 320-328. doi: https://doi.org/10.1590/0100-3984.2020.0074
Fonseca EK, Ferreira LC, Loureiro BM, Strabelli DG, Farias LP, Queiroz GA, et al. Tomografia computadorizada de tórax no diagnóstico de COVID-19 em pacientes com resultado falso-negativo na RT-PCR. Einstein (São Paulo). 2021;19:AO6363. doi: https://doi.org/10.31744/einstein_journal/2021AO6363
REVISA.2024 Abr-Jun; 13(2):489-501
Silva MF, Araújo MG, Araújo JNM, Cabral AEA, Dantas AC, Vitor AF
Li Y, Xia L. Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management. AJR Am J Roentgenol. 2020;214(6):1280-1286. doi: https://doi.org/10.2214/AJR.20.22954
Wang Z, Wang Z. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak. BMC Infect Dis. 2021;21(113). doi: https://doi.org/10.1186/s12879-021-05814-4
Graña C, Ghosn L, Evrenoglou T, Jarde A, Minozzi S, Bergman H, et al. Efficacy and safety of COVID-19 vaccines. Cochrane Database Syst Rev. 2022;12(12):CD015477. doi: https://doi.org/10.1002/14651858.CD015477
Lopez Bernal J, Andrews N, Gower C, Robertson C, Stowe J, Tessier E, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021;373:n1088. doi: https://doi.org/10.1136/bmj.n1088
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista de Divulgação Científica Sena Aires

This work is licensed under a Creative Commons Attribution 4.0 International License.
-
Atribuição — Você deve dar o crédito apropriado, prover um link para a licença e indicar se mudanças foram feitas. Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
- Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.